Minimally invasive surgical procedures are potentially safer, easier on patients during recovery, and can even reduce the cost burden on hospitals, when compared with conventional open surgeries. There are still serious risks that are involved, in large part arising from the laparoscopy sites that need to be punched in the abdomen through which ins (Read more...)
Only 17% of patients with uveitis receive systemic disease evaluation, diagnoses
DESTIN, Fla. — Despite the common association with autoimmune diseases, just 17% of patients with uveitis are evaluated for, or diagnosed with, a systemic autoimmune disease when receiving ophthalmology care, according to a presenter at the 2019 North …
Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa
VANCOUVER, British Columbia — Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa.ReNeuron chief medical offic…
Rice Students Develop Non-Invasive Intracranial Pressure Sensor to Monitor Infants
Infants that experience injury or that have hydrocephalus may have swelling or fluid build-up, which can result in a high intracranial pressure (ICP). Because there are serious, life-long consequences that may result, monitoring the ICP may help doctors monitor infants, diagnose hydrocephalus, and help decide when to take interventional measures. T (Read more...)
Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive Surgery
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
STAAR Surgical Announces Expanded Recommended Diopter Range for EVO Visian ICL by Refractive Societies in Germany and Japan
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the leading refractive ophthalmic societies in…